VSee Health Statistics
Total Valuation
VSee Health has a market cap or net worth of $11.03 million. The enterprise value is $9.02 million.
Important Dates
The last earnings date was Wednesday, April 1, 2026, after market close.
| Earnings Date | Apr 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VSee Health has 47.30 million shares outstanding. The number of shares has increased by 97.23% in one year.
| Current Share Class | 47.30M |
| Shares Outstanding | 47.30M |
| Shares Change (YoY) | +97.23% |
| Shares Change (QoQ) | +89.04% |
| Owned by Insiders (%) | 17.42% |
| Owned by Institutions (%) | 4.81% |
| Float | 33.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.75 |
| Forward PS | n/a |
| PB Ratio | 1.42 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.51, with a Debt / Equity ratio of 0.60.
| Current Ratio | 0.51 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.41 |
Financial Efficiency
Return on equity (ROE) is -541.52% and return on invested capital (ROIC) is -228.24%.
| Return on Equity (ROE) | -541.52% |
| Return on Assets (ROA) | -28.25% |
| Return on Invested Capital (ROIC) | -228.24% |
| Return on Capital Employed (ROCE) | -155.35% |
| Weighted Average Cost of Capital (WACC) | 21.56% |
| Revenue Per Employee | $94,923 |
| Profits Per Employee | -$95,538 |
| Employee Count | 154 |
| Asset Turnover | 0.69 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VSee Health has paid $68,426 in taxes.
| Income Tax | 68,426 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.45% in the last 52 weeks. The beta is 0.64, so VSee Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -80.45% |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | 0.63 |
| Relative Strength Index (RSI) | 41.27 |
| Average Volume (20 Days) | 559,511 |
Short Selling Information
The latest short interest is 1.01 million, so 2.13% of the outstanding shares have been sold short.
| Short Interest | 1.01M |
| Short Previous Month | 1.40M |
| Short % of Shares Out | 2.13% |
| Short % of Float | 3.00% |
| Short Ratio (days to cover) | 1.78 |
Income Statement
In the last 12 months, VSee Health had revenue of $14.62 million and -$14.71 million in losses. Loss per share was -$0.73.
| Revenue | 14.62M |
| Gross Profit | 7.36M |
| Operating Income | -9.58M |
| Pretax Income | -14.64M |
| Net Income | -14.71M |
| EBITDA | -7.00M |
| EBIT | -9.58M |
| Loss Per Share | -$0.73 |
Full Income StatementBalance Sheet
The company has $5.27 million in cash and $3.26 million in debt, with a net cash position of $2.01 million or $0.04 per share.
| Cash & Cash Equivalents | 5.27M |
| Total Debt | 3.26M |
| Net Cash | 2.01M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 5.45M |
| Book Value Per Share | 0.16 |
| Working Capital | -7.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.45 million and capital expenditures -$29,928, giving a free cash flow of -$3.48 million.
| Operating Cash Flow | -3.45M |
| Capital Expenditures | -29,928 |
| Depreciation & Amortization | 2.59M |
| Net Borrowing | 1.59M |
| Free Cash Flow | -3.48M |
| FCF Per Share | -$0.07 |
Full Cash Flow StatementMargins
Gross margin is 50.32%, with operating and profit margins of -65.55% and -100.65%.
| Gross Margin | 50.32% |
| Operating Margin | -65.55% |
| Pretax Margin | -100.18% |
| Profit Margin | -100.65% |
| EBITDA Margin | -47.85% |
| EBIT Margin | -65.55% |
| FCF Margin | n/a |
Dividends & Yields
VSee Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -97.23% |
| Shareholder Yield | -97.23% |
| Earnings Yield | -133.39% |
| FCF Yield | -31.51% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VSee Health has an Altman Z-Score of -5.69 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.69 |
| Piotroski F-Score | 2 |
